Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Clinical trial NCT03159364 · RECRUITING

Trial details

NCT number: NCT03159364
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pathogen Infection EBV Infection CMV Infection Adenovirus Infection BKV Infection Fungus Infection Tuberculosis

Start date: 2026-06-01
Primary completion: 2029-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.